Skip to content
PreclinicalResearch compound

Latanoprost

Glaucoma eye drop; using it for hair loss is off-label, experimental and not proven in humans.

Available at
MINOXIDILMAX logo
MINOXIDILMAXProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Latanoprost vial

DETAILED OVERVIEW

What is Latanoprost?

Latanoprost is a prescription eye drop approved for glaucoma and high pressure in the eye, for example under the name Xalatan. It is not approved for hair loss: using it on the scalp is off-label and experimental. A known side effect of the eye drop is that eyelashes grow longer and darker. The approved eyelash-growth product, however, is bimatoprost, not latanoprost.

It is thought to prolong the growth phase of hair follicles. In a small placebo-controlled pilot study, hair density increased compared with placebo in men with early male pattern hair loss. Combinations with minoxidil are also being studied. It is not proven for hair loss in humans, the evidence is still early, and there is little data on long-term safety. On the scalp it can cause skin irritation and darkening of the skin or hair, and if it gets into the eye it can change the colour of the iris.

Class

Prostaglandin F2-alpha analog (FP-receptor agonist)

Status

Approved for glaucoma; scalp/AGA off-label, experimental

Mechanism of action

Prolongs the anagen phase via the FP receptor

Form

Topical scalp, ~0.1% solution in the pilot

Evidence

Early, pilot-level RCT (24 weeks)

Data console

Lab data

Classification-
StructureN/A
Molecular weightN/A
Target area-
Storage2–8°C
Stability~30 days reconstituted

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • Local skin irritation on the scalp
  • Skin or hair darkening (hyperpigmentation), mirroring the periocular pigmentation seen with ocular use
  • With ocular use, eyelash growth and darkening, and iris pigmentation
  • Limited long-term scalp safety data (investigational use)

Contraindications · 3

  • Avoid eye contact during scalp use: ocular exposure can cause iris pigmentation
  • Known hypersensitivity to latanoprost or any component of the product
  • Scalp/hair-loss use is off-label and investigational with limited long-term safety data: it does not replace proven treatments and is not advised without dermatology guidance

Related Hair & Skin

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Latanoprost?

Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 12, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.